EyePoint Pharmaceuticals Inc (EYPT)
12.08
-0.58
(-4.62%)
USD |
NASDAQ |
May 10, 16:00
12.08
0.00 (0.00%)
After-Hours: 20:00
EyePoint Pharmaceuticals Cash from Operations (TTM): 1.875M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.875M |
| September 30, 2023 | 12.40M |
| June 30, 2023 | 14.46M |
| March 31, 2023 | -61.68M |
| December 31, 2022 | -65.00M |
| September 30, 2022 | -69.08M |
| June 30, 2022 | -63.74M |
| March 31, 2022 | -55.16M |
| December 31, 2021 | -50.10M |
| September 30, 2021 | -27.53M |
| June 30, 2021 | -18.61M |
| March 31, 2021 | -13.19M |
| December 31, 2020 | -14.44M |
| September 30, 2020 | -31.82M |
| June 30, 2020 | -47.72M |
| March 31, 2020 | -59.71M |
| December 31, 2019 | -56.70M |
| September 30, 2019 | -56.98M |
| June 30, 2019 | -48.29M |
| March 31, 2019 | -36.00M |
| September 30, 2018 | -27.70M |
| June 30, 2018 | -21.91M |
| March 31, 2018 | -20.28M |
| December 31, 2017 | -20.00M |
| September 30, 2017 | -19.97M |
| Date | Value |
|---|---|
| June 30, 2017 | -20.49M |
| March 31, 2017 | -20.38M |
| December 31, 2016 | -20.14M |
| September 30, 2016 | -18.31M |
| June 30, 2016 | -16.32M |
| March 31, 2016 | -14.98M |
| December 31, 2015 | -14.63M |
| September 30, 2015 | 9.798M |
| June 30, 2015 | 10.30M |
| March 31, 2015 | 10.52M |
| December 31, 2014 | 12.62M |
| September 30, 2014 | -10.89M |
| June 30, 2014 | -10.67M |
| March 31, 2014 | -11.27M |
| December 31, 2013 | -11.38M |
| September 30, 2013 | -10.90M |
| June 30, 2013 | -8.745M |
| March 31, 2013 | -7.203M |
| December 31, 2012 | -7.384M |
| September 30, 2012 | -7.962M |
| June 30, 2012 | -9.001M |
| March 31, 2012 | -5.918M |
| December 31, 2011 | -5.388M |
| September 30, 2011 | -3.611M |
| June 30, 2011 | -3.17M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-69.08M
Minimum
Sep 2022
14.46M
Maximum
Jun 2023
-37.42M
Average
-48.29M
Median
Jun 2019
Cash from Operations (TTM) Benchmarks
| Nanoviricides Inc | -6.127M |
| Bio-Path Holdings Inc | -11.54M |
| GlycoMimetics Inc | -34.88M |
| Ocular Therapeutix Inc | -70.23M |
| Aileron Therapeutics Inc | -19.81M |